Glaukos Corp
NYSE:GKOS

Watchlist Manager
Glaukos Corp Logo
Glaukos Corp
NYSE:GKOS
Watchlist
Price: 142.22 USD -0.71%
Market Cap: 7.8B USD
Have any thoughts about
Glaukos Corp?
Write Note

Wall Street
Price Targets

GKOS Price Targets Summary
Glaukos Corp

Wall Street analysts forecast GKOS stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GKOS is 139.94 USD with a low forecast of 116.15 USD and a high forecast of 159.6 USD.

Lowest
Price Target
116.15 USD
18% Downside
Average
Price Target
139.94 USD
2% Downside
Highest
Price Target
159.6 USD
12% Upside

GKOS Last Price Targets
Glaukos Corp

The latest public price target was made on Nov 5, 2024 by Ryan Zimmerman from BTIG , who expects GKOS stock to drop by 2% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Ryan Zimmerman
BTIG
140 USD
Downside 2%
1 week ago
Nov 5, 2024
Glaukos Corporation (GKOS) PT Raised to $140 at BTIG
StreetInsider
David Saxon
Needham
149 USD
Upside 5%
1 week ago
Nov 5, 2024
Needham Reiterates Buy Rating on Glaukos Corporation (GKOS)
StreetInsider
Michael Sarcone
Jefferies
155 USD
Upside 9%
2 weeks ago
Oct 29, 2024
Glaukos Corporation (GKOS) PT Raised to $155 at Jefferies
StreetInsider
Samuel Brodovsky
Truist Financial
152 USD
Upside 7%
3 weeks ago
Oct 21, 2024
Truist Securities Reiterates Buy Rating on Glaukos Corporation (GKOS)
StreetInsider
Matt O'Brien
Piper Sandler
140 USD
Downside 2%
4 weeks ago
Oct 17, 2024
Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
StreetInsider
Ryan Zimmerman
BTIG
139 USD
Downside 2%
1 month ago
Sep 23, 2024
BTIG Reiterates Buy Rating on Glaukos Corporation (GKOS)
StreetInsider
Thomas Stephan
Stifel Nicolaus
145 USD
Upside 2%
2 months ago
Sep 3, 2024
Glaukos Corporation (GKOS) PT Raised to $145 at Stifel
StreetInsider
Thomas Stephan
Stifel Nicolaus
130 USD
Downside 9%
5 months ago
Jun 5, 2024
Glaukos Corporation (GKOS) PT Raised to $130 at Stifel
StreetInsider
Larry Biegelsen
Wells Fargo
120 USD
Downside 16%
5 months ago
Jun 3, 2024
Glaukos price target raised to $120 from $110 at Wells Fargo
TheFly
Samuel Brodovsky
Truist Financial
125 USD
Downside 12%
5 months ago
May 28, 2024
Truist Securities Reiterates Buy Rating on Glaukos Corporation (GKOS)
StreetInsider
Matt O'Brien
Piper Sandler
110 USD
Downside 23%
5 months ago
May 21, 2024
Piper Sandler Reiterates Overweight Rating on Glaukos Corporation (GKOS)
StreetInsider
Michael Sarcone
Jefferies
125 USD
Downside 12%
6 months ago
May 6, 2024
Jefferies Upgrades Glaukos Corporation (GKOS) to Buy
StreetInsider
David Saxon
Needham
113 USD
Downside 21%
6 months ago
May 2, 2024
Glaukos Corporation (GKOS) PT Raised to $113 at Needham
StreetInsider
Show More Price Targets
Show Less Price Targets
Ryan Zimmerman
BTIG
Price Target 140 USD
Upside/Downside 2%
View Source
David Saxon
Needham
Price Target 149 USD
Upside/Downside 5%
View Source
Michael Sarcone
Jefferies
Price Target 155 USD
Upside/Downside 9%
View Source
Samuel Brodovsky
Truist Financial
Price Target 152 USD
Upside/Downside 7%
View Source
Matt O'Brien
Piper Sandler
Price Target 140 USD
Upside/Downside 2%
View Source
Ryan Zimmerman
BTIG
Price Target 139 USD
Upside/Downside 2%
View Source
Thomas Stephan
Stifel Nicolaus
Price Target 145 USD
Upside/Downside 2%
View Source
Thomas Stephan
Stifel Nicolaus
Price Target 130 USD
Upside/Downside 9%
View Source
Larry Biegelsen
Wells Fargo
Price Target 120 USD
Upside/Downside 16%
View Source
Samuel Brodovsky
Truist Financial
Price Target 125 USD
Upside/Downside 12%
View Source
Matt O'Brien
Piper Sandler
Price Target 110 USD
Upside/Downside 23%
View Source
Michael Sarcone
Jefferies
Price Target 125 USD
Upside/Downside 12%
View Source
David Saxon
Needham
Price Target 113 USD
Upside/Downside 21%
View Source
Show More Price Targets
Show Less Price Targets
Glaukos Corp Competitors:
Price Targets
2252
Shanghai MicroPort MedBot Group Co Ltd
102% Upside
MLAB
Mesa Laboratories Inc
36% Upside
MLSS
Milestone Scientific Inc
227% Upside
ABT
Abbott Laboratories
14% Upside
AXGN
AxoGen Inc
34% Upside
SENS
Senseonics Holdings Inc
404% Upside
SN
Smith & Nephew PLC
41% Upside
688580
Nanjing Vishee Medical Technology Co Ltd
22% Upside

Revenue
Forecast

Revenue Estimate
Glaukos Corp

For the last 8 years the compound annual growth rate for Glaukos Corp's revenue is 20%. The projected CAGR for the next 3 years is 24%.

20%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Glaukos Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Glaukos Corp

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GKOS's stock price target?
Price Target
139.94 USD

According to Wall Street analysts, the average 1-year price target for GKOS is 139.94 USD with a low forecast of 116.15 USD and a high forecast of 159.6 USD.

What is Glaukos Corp's Revenue forecast?
Projected CAGR
24%

For the last 8 years the compound annual growth rate for Glaukos Corp's revenue is 20%. The projected CAGR for the next 3 years is 24%.

Back to Top